Cytiva_APR21_EarlyProcessDevDecisions - 7

EARLY PROCESS DEVELOPMENT DECISIONS PAY OFF FOR CELL AND GENE THERAPIES

capacity, Dasburg says. " Isolators are probably

in an array within a single ballroom-like facility

the number one investment to make. Too many

providing 100% containment going from leuka-

people are trying to work five people in full dress

pheresis bag to treatment bag without any

in a small room attempting to manufacture in

human intervention. "

a hands-on traditional way when isolation and
automation could help immensely. "
Dasburg pointed to benchtop platforms
capable of processing a single CAR-T patient's
treatment as an example of an innovative
approach being used. " These can be arranged

n

 

REFERENCES
1.	alliancerm.org/wp-content/uploads/2020/02/CBX-Meeting-7-Feb2020-FINAL.pdf
2. 	 aabme.asme.org/posts/virus-shortage-for-cell-therapies-creates-engineering-opportunity
3. 	 www.genengnews.com/insights/gene-therapy-dollar-is-waitingon-viral-vector-dime/

GENengnews.com

|7


http://alliancerm.org/wp-content/uploads/2020/02/CBX-Meeting-7-Feb-2020-FINAL.pdf http://alliancerm.org/wp-content/uploads/2020/02/CBX-Meeting-7-Feb-2020-FINAL.pdf http://aabme.asme.org/posts/virus-shortage-for-cell-therapies-creates-engineering-opportunity http://aabme.asme.org/posts/virus-shortage-for-cell-therapies-creates-engineering-opportunity http://www.genengnews.com/insights/gene-therapy-dollar-is-waiting-on-viral-vector-dime/ http://www.genengnews.com/insights/gene-therapy-dollar-is-waiting-on-viral-vector-dime/ http://www.GENengnews.com

Cytiva_APR21_EarlyProcessDevDecisions

Table of Contents for the Digital Edition of Cytiva_APR21_EarlyProcessDevDecisions

Contents
Cytiva_APR21_EarlyProcessDevDecisions - Cover1
Cytiva_APR21_EarlyProcessDevDecisions - Cover2
Cytiva_APR21_EarlyProcessDevDecisions - Contents
Cytiva_APR21_EarlyProcessDevDecisions - 4
Cytiva_APR21_EarlyProcessDevDecisions - 5
Cytiva_APR21_EarlyProcessDevDecisions - 6
Cytiva_APR21_EarlyProcessDevDecisions - 7
Cytiva_APR21_EarlyProcessDevDecisions - 8
Cytiva_APR21_EarlyProcessDevDecisions - 9
Cytiva_APR21_EarlyProcessDevDecisions - 10
Cytiva_APR21_EarlyProcessDevDecisions - 11
Cytiva_APR21_EarlyProcessDevDecisions - 12
Cytiva_APR21_EarlyProcessDevDecisions - 13
Cytiva_APR21_EarlyProcessDevDecisions - 14
Cytiva_APR21_EarlyProcessDevDecisions - 15
Cytiva_APR21_EarlyProcessDevDecisions - 16
Cytiva_APR21_EarlyProcessDevDecisions - 17
Cytiva_APR21_EarlyProcessDevDecisions - 18
Cytiva_APR21_EarlyProcessDevDecisions - 19
Cytiva_APR21_EarlyProcessDevDecisions - 20
Cytiva_APR21_EarlyProcessDevDecisions - 21
Cytiva_APR21_EarlyProcessDevDecisions - 22
Cytiva_APR21_EarlyProcessDevDecisions - 23
Cytiva_APR21_EarlyProcessDevDecisions - 24
Cytiva_APR21_EarlyProcessDevDecisions - 25
Cytiva_APR21_EarlyProcessDevDecisions - 26
Cytiva_APR21_EarlyProcessDevDecisions - 27
Cytiva_APR21_EarlyProcessDevDecisions - 28
Cytiva_APR21_EarlyProcessDevDecisions - 29
Cytiva_APR21_EarlyProcessDevDecisions - 30
Cytiva_APR21_EarlyProcessDevDecisions - 31
Cytiva_APR21_EarlyProcessDevDecisions - 32
Cytiva_APR21_EarlyProcessDevDecisions - 33
Cytiva_APR21_EarlyProcessDevDecisions - 34
Cytiva_APR21_EarlyProcessDevDecisions - 35
Cytiva_APR21_EarlyProcessDevDecisions - 36
Cytiva_APR21_EarlyProcessDevDecisions - Cover3
Cytiva_APR21_EarlyProcessDevDecisions - Cover4
https://www.nxtbookmedia.com